Estados Unidos

Mercado internacional de ações

Cadastro completo das bolsas americanas, histórico de preços, demonstrações financeiras, indicadores, rentabilidade, crescimento, endividamento, qualidade, mercado e dividendos.

Ações ordinárias, common stocks e ADRs/ADSs ativos; ETFs, units, warrants, direitos e preferenciais ficam fora desta aba.

Explorar REITs americanos

5.660

ações no escopo

5.646

ligadas à SEC

5.651

com preços

5.119

com fundamentos

18/09/2026

última cotação

SEC como fonte principal

Identidade regulatória, demonstrações anuais e trimestrais e dividendos declarados vêm do EDGAR/XBRL.

Cadastro oficial

Nasdaq Trader cobre Nasdaq, NYSE, NYSE American, NYSE Arca, Cboe e IEX.

Proveniência explícita

A janela pública da Nasdaq tem prioridade; Yahoo Finance completa o período anterior sem ser rotulado como oficial.

Destaques do mercado

Ranking de Stocks

Listas objetivas calculadas sobre todo o universo de ações dos EUA, com preços de mercado e fundamentos SEC.

Top 5

Todas as ações

502 resultados

Ação	Bolsa	Preço	Valor de mercado	P/L

MLYSMineralys Therapeutics, Inc. - Common Stock	NASDAQ	US$ 28,20	US$ 1,91 bi	—	2,95x	-23,91%	—	Preço 11/09/2026 SEC 31/12/2025
PRGOPerrigo Company plc Ordinary Shares	NYSE	US$ 13,66	US$ 1,89 bi	—	0,64x	-48,56%	8,49%	Preço 11/09/2026 SEC 31/12/2025
SLNSilence Therapeutics Plc - American Depository Share	NASDAQ	US$ 13,02	US$ 1,84 bi	—	29,61x	-142,23%	—	Preço 11/09/2026 SEC 31/12/2025
XNCRXencor, Inc. - Common Stock	NASDAQ	US$ 24,53	US$ 1,82 bi	—	2,87x	-14,46%	—	Preço 14/09/2026 SEC 31/12/2025
NBTXNanobiotix S.A. - ADSs	NASDAQ	US$ 37,01	US$ 1,79 bi	—	-21,21x	28,36%	—	Preço 11/09/2026 SEC 31/12/2025
IMUXImmunic, Inc. - Common Stock	NASDAQ	US$ 11,42	US$ 1,78 bi	—	-266,44x	1.456,20%	0,00%	Preço 11/09/2026 SEC 31/12/2025
LKFTLakefront Biotherapeutics - American Depositary Shares	NASDAQ	US$ 26,81	US$ 1,77 bi	5,51x	0,55x	9,92%	—	Preço 11/09/2026 SEC 31/12/2025
STOKStoke Therapeutics, Inc. - Common Stock	NASDAQ	US$ 29,60	US$ 1,75 bi	—	4,97x	-1,95%	—	Preço 14/09/2026 SEC 31/12/2025
INVAInnoviva, Inc. - Common Stock	NASDAQ	US$ 20,66	US$ 1,75 bi	6,26x	1,49x	—	—	Preço 11/09/2026 SEC 31/12/2025
RAPPRapport Therapeutics, Inc. - Common Stock	NASDAQ	US$ 44,18	US$ 1,72 bi	—	3,55x	-23,00%	—	Preço 14/09/2026 SEC 31/12/2025
SEPNSepterna, Inc. - Common Stock	NASDAQ	US$ 38,51	US$ 1,70 bi	—	4,46x	-12,80%	—	Preço 11/09/2026 SEC 31/12/2025
PVLAPalvella Therapeutics, Inc. - Common Stock	NASDAQ	US$ 150,13	US$ 1,69 bi	—	60,36x	-149,07%	—	Preço 11/09/2026 SEC 31/12/2025
GHRSGH Research PLC - Ordinary Shares	NASDAQ	US$ 27,20	US$ 1,69 bi	—	6,03x	-17,25%	—	Preço 11/09/2026 SEC 31/12/2025
ANIPANI Pharmaceuticals, Inc. - Common Stock	NASDAQ	US$ 76,14	US$ 1,62 bi	22,93x	2,99x	14,49%	—	Preço 18/09/2026 SEC 31/12/2025
ANABAnaptysBio, Inc. - Common Stock	NASDAQ	US$ 55,20	US$ 1,59 bi	—	42,66x	-35,56%	—	Preço 18/09/2026 SEC 31/12/2025
SNDXSyndax Pharmaceuticals, Inc. - Common Stock	NASDAQ	US$ 18,18	US$ 1,57 bi	—	24,37x	-441,62%	—	Preço 11/09/2026 SEC 31/12/2025
PAHCPhibro Animal Health Corporation - Class A Common Stock	NASDAQ	US$ 35,62	US$ 1,46 bi	14,66x	3,79x	25,87%	1,35%	Preço 11/09/2026 SEC 30/06/2026
CMMBChemomab Therapeutics Ltd. - American Depositary Shares	NASDAQ	US$ 2,47	US$ 1,42 bi	137,22x	115,23x	-72,93%	—	Preço 15/09/2026 SEC 31/12/2025
SDGRSchrodinger, Inc. - Common Stock	NASDAQ	US$ 19,02	US$ 1,40 bi	—	3,84x	-28,37%	—	Preço 11/09/2026 SEC 31/12/2025
ZBIOZenas BioPharma, Inc. - Common Stock	NASDAQ	US$ 31,12	US$ 1,39 bi	—	5,75x	-156,00%	—	Preço 11/09/2026 SEC 31/12/2025
RAREUltragenyx Pharmaceutical Inc. - Common Stock	NASDAQ	US$ 13,87	US$ 1,37 bi	—	-17,09x	718,75%	—	Preço 14/09/2026 SEC 31/12/2025
BHVNBiohaven Ltd. Common Shares	NYSE	US$ 12,34	US$ 1,33 bi	—	25,50x	-1.418,85%	—	Preço 15/09/2026 SEC 31/12/2025
TYRATyra Biosciences, Inc. - Common Stock	NASDAQ	US$ 22,03	US$ 1,31 bi	—	5,07x	-46,28%	—	Preço 11/09/2026 SEC 31/12/2025
CMPSCOMPASS Pathways Plc - American Depository Shares	NASDAQ	US$ 13,81	US$ 1,29 bi	—	-24,43x	544,70%	—	Preço 15/09/2026 SEC 31/12/2025
XERSXeris Biopharma Holdings, Inc. - Common Stock	NASDAQ	US$ 7,45	US$ 1,29 bi	—	94,01x	4,05%	—	Preço 11/09/2026 SEC 31/12/2025
HROWHarrow, Inc. - Common Stock	NASDAQ	US$ 34,48	US$ 1,27 bi	—	24,33x	-9,87%	—	Preço 11/09/2026 SEC 31/12/2025
SLSSELLAS Life Sciences Group, Inc. - Common Stock	NASDAQ	US$ 11,55	US$ 1,26 bi	—	17,76x	-37,90%	—	Preço 11/09/2026 SEC 31/12/2025
SVRASavara, Inc. - Common Stock	NASDAQ	US$ 5,34	US$ 1,19 bi	—	-13.649,99x	136.594,25%	—	Preço 14/09/2026 SEC 31/12/2025
OPKOpko Health, Inc. - Common Stock	NASDAQ	US$ 1,57	US$ 1,18 bi	—	0,93x	-17,80%	—	Preço 11/09/2026 SEC 31/12/2025
MNKDMannKind Corporation - Common Stock	NASDAQ	US$ 3,75	US$ 1,18 bi	187,50x	-23,09x	-11,49%	—	Preço 11/09/2026 SEC 31/12/2025
NKTRNektar Therapeutics - Common Stock	NASDAQ	US$ 69,19	US$ 1,17 bi	—	13,00x	-182,65%	—	Preço 14/09/2026 SEC 31/12/2025
PCRXPacira BioSciences, Inc. - Common Stock	NASDAQ	US$ 25,36	US$ 1,14 bi	158,50x	1,65x	1,01%	—	Preço 11/09/2026 SEC 31/12/2025
AMPHAmphastar Pharmaceuticals, Inc. - Common Stock	NASDAQ	US$ 23,62	US$ 1,14 bi	11,64x	1,44x	12,44%	—	Preço 18/09/2026 SEC 31/12/2025
YARWYarrow Bioscience, Inc. - Common Stock	NASDAQ	US$ 26,26	US$ 1,12 bi	—	40,45x	-95,38%	—	Preço 14/09/2026 SEC 31/12/2025
AVBPArriVent BioPharma, Inc. - Common Stock	NASDAQ	US$ 28,90	US$ 1,11 bi	—	3,62x	-54,13%	—	Preço 18/09/2026 SEC 31/12/2025
JANXJanux Therapeutics, Inc. - Common Stock	NASDAQ	US$ 17,10	US$ 1,06 bi	—	1,11x	-11,88%	—	Preço 11/09/2026 SEC 31/12/2025
ORICOric Pharmaceuticals, Inc. - Common Stock	NASDAQ	US$ 12,04	US$ 1,06 bi	—	2,75x	-33,68%	—	Preço 11/09/2026 SEC 31/12/2025
CRVSCorvus Pharmaceuticals, Inc. - Common Stock	NASDAQ	US$ 12,95	US$ 1,03 bi	—	16,87x	-24,97%	—	Preço 15/09/2026 SEC 31/12/2025
KURAKura Oncology, Inc. - Common Stock	NASDAQ	US$ 11,39	US$ 998,63 mi	—	5,73x	-160,03%	—	Preço 11/09/2026 SEC 31/12/2025
ABUSArbutus Biopharma Corporation - Common Stock	NASDAQ	US$ 5,01	US$ 959,91 mi	—	12,54x	-43,75%	—	Preço 18/09/2026 SEC 31/12/2025
CLYMClimb Bio, Inc. - Common Stock	NASDAQ	US$ 13,91	US$ 943,27 mi	—	5,88x	-37,30%	—	Preço 15/09/2026 SEC 31/12/2025
MRVIMaravai LifeSciences Holdings, Inc. - Class A common stock	NASDAQ	US$ 6,53	US$ 942,67 mi	—	2,53x	-35,09%	—	Preço 11/09/2026 SEC 31/12/2025
GERNGeron Corporation - Common Stock	NASDAQ	US$ 1,35	US$ 900,00 mi	—	3,98x	-36,97%	—	Preço 11/09/2026 SEC 31/12/2025
OLMAOlema Pharmaceuticals, Inc. - Common Stock	NASDAQ	US$ 10,22	US$ 889,20 mi	—	1,86x	-33,95%	—	Preço 11/09/2026 SEC 31/12/2025
COLLCollegium Pharmaceutical, Inc. - Common Stock	NASDAQ	US$ 22,19	US$ 880,98 mi	12,83x	2,92x	20,84%	—	Preço 16/09/2026 SEC 31/12/2025
TBPHTheravance Biopharma, Inc. - Ordinary Shares	NASDAQ	US$ 17,01	US$ 876,13 mi	8,26x	2,95x	35,69%	—	Preço 11/09/2026 SEC 31/12/2025
ANROAlto Neuroscience, Inc. Common Stock	NYSE	US$ 30,27	US$ 873,35 mi	—	5,78x	-41,84%	—	Preço 18/09/2026 SEC 31/12/2025
RIGLRigel Pharmaceuticals, Inc. - Common Stock	NASDAQ	US$ 45,32	US$ 853,74 mi	2,33x	2,18x	93,75%	—	Preço 14/09/2026 SEC 31/12/2025
ARDXArdelyx, Inc. - Common Stock	NASDAQ	US$ 3,42	US$ 824,34 mi	—	4,94x	-36,90%	—	Preço 18/09/2026 SEC 31/12/2025
CYRXCryoPort, Inc. - Common Stock	NASDAQ	US$ 16,31	US$ 816,67 mi	11,65x	1,62x	15,58%	—	Preço 15/09/2026 SEC 31/12/2025
MLTXMoonLake Immunotherapeutics - Class A Ordinary Shares	NASDAQ	US$ 12,51	US$ 806,44 mi	—	2,65x	-74,66%	—	Preço 11/09/2026 SEC 31/12/2025
WVEWave Life Sciences, Inc. - Common Stock	NASDAQ	US$ 4,59	US$ 774,10 mi	—	1,49x	-39,43%	—	Preço 11/09/2026 SEC 31/12/2025
NGNENeurogene Inc. - Common Stock	NASDAQ	US$ 35,48	US$ 756,66 mi	—	2,86x	-34,11%	—	Preço 11/09/2026 SEC 31/12/2025
LXRXLexicon Pharmaceuticals, Inc. - Common Stock	NASDAQ	US$ 2,00	US$ 724,29 mi	—	6,74x	-46,81%	—	Preço 14/09/2026 SEC 31/12/2025
DSGNDesign Therapeutics, Inc. - Common Stock	NASDAQ	US$ 12,23	US$ 700,86 mi	—	3,30x	-32,84%	—	Preço 15/09/2026 SEC 31/12/2025
GYREGyre Therapeutics, Inc. - Common Stock	NASDAQ	US$ 6,73	US$ 694,40 mi	336,50x	4,88x	6,94%	—	Preço 11/09/2026 SEC 31/12/2025
ZVRAZevra Therapeutics, Inc. - Common Stock	NASDAQ	US$ 12,01	US$ 687,73 mi	8,90x	4,45x	53,82%	—	Preço 11/09/2026 SEC 31/12/2025
ACRSAclaris Therapeutics, Inc. - Common Stock	NASDAQ	US$ 5,50	US$ 674,11 mi	—	6,54x	-62,98%	—	Preço 18/09/2026 SEC 31/12/2025
IRWDIronwood Pharmaceuticals, Inc. - Class A Common Stock	NASDAQ	US$ 4,08	US$ 664,97 mi	27,20x	-2,54x	-9,17%	—	Preço 11/09/2026 SEC 31/12/2025
ALMSAlumis Inc. - Common Stock	NASDAQ	US$ 7,77	US$ 660,68 mi	—	2,19x	-80,76%	—	Preço 18/09/2026 SEC 31/12/2025
ANNXAnnexon, Inc. - common stock	NASDAQ	US$ 4,23	US$ 656,10 mi	—	3,10x	-97,66%	0,00%	Preço 18/09/2026 SEC 31/12/2025
PHATPhathom Pharmaceuticals, Inc. - Common Stock	NASDAQ	US$ 8,36	US$ 609,60 mi	—	-1,39x	50,49%	—	Preço 11/09/2026 SEC 31/12/2025
ARVNArvinas, Inc. - Common Stock	NASDAQ	US$ 8,29	US$ 587,76 mi	—	1,35x	-18,62%	—	Preço 18/09/2026 SEC 31/12/2025
JBIOJade Biosciences, Inc. - Common Stock	NASDAQ	US$ 17,89	US$ 561,03 mi	—	1,69x	-38,32%	—	Preço 11/09/2026 SEC 31/12/2025
IMMPImmutep Limited - American Depositary Shares	NASDAQ	US$ 0,37	US$ 545,16 mi	—	3,80x	-42,77%	—	Preço 11/09/2026 SEC 30/06/2025
NVCTNuvectis Pharma, Inc. - Common Stock	NASDAQ	US$ 23,69	US$ 516,74 mi	—	28,06x	-143,61%	0,00%	Preço 14/09/2026 SEC 31/12/2025
BNTCBenitec Biopharma Inc. - Common Stock	NASDAQ	US$ 11,05	US$ 514,47 mi	—	2,91x	-25,73%	—	Preço 15/09/2026 SEC 30/06/2026
VSTMVerastem, Inc. - Common Stock	NASDAQ	US$ 7,32	US$ 507,34 mi	—	8,87x	-366,23%	—	Preço 11/09/2026 SEC 31/12/2025
EOLSEvolus, Inc. - Common Stock	NASDAQ	US$ 7,84	US$ 505,44 mi	—	-21,87x	223,50%	—	Preço 11/09/2026 SEC 31/12/2025
AQSTAquestive Therapeutics, Inc. - Common Stock	NASDAQ	US$ 4,61	US$ 492,93 mi	—	-14,64x	248,90%	—	Preço 18/09/2026 SEC 31/12/2025
PRTAProthena Corporation plc - Ordinary Shares	NASDAQ	US$ 8,93	US$ 480,69 mi	—	1,71x	-87,03%	—	Preço 11/09/2026 SEC 31/12/2025
SPRYARS Pharmaceuticals, Inc. - Common Stock	NASDAQ	US$ 4,76	US$ 469,18 mi	—	4,11x	-149,92%	—	Preço 11/09/2026 SEC 31/12/2025
SVASinovac Biotech, Ltd. - Ordinary Shares (Antigua/Barbudo)	NASDAQ	US$ 6,47	US$ 464,94 mi	—	0,07x	—	850,08%	Preço 11/09/2026 SEC 31/12/2025
PBYIPuma Biotechnology Inc - Common Stock	NASDAQ	US$ 9,12	US$ 461,96 mi	14,95x	3,54x	23,87%	—	Preço 11/09/2026 SEC 31/12/2025
CTMXCytomX Therapeutics, Inc. - Common Stock	NASDAQ	US$ 2,69	US$ 457,80 mi	—	4,62x	-17,54%	—	Preço 15/09/2026 SEC 31/12/2025
KMDAKamada Ltd. - Ordinary Shares	NASDAQ	US$ 7,92	US$ 456,87 mi	22,63x	1,70x	7,51%	—	Preço 11/09/2026 SEC 31/12/2025
ARCTArcturus Therapeutics Holdings Inc. - Common Stock	NASDAQ	US$ 16,03	US$ 439,00 mi	—	2,05x	-30,74%	—	Preço 18/09/2026 SEC 31/12/2025
ADXNAddex Therapeutics Ltd - American Depositary Shares	NASDAQ	US$ 3,40	US$ 436,20 mi	48,57x	45,07x	72,91%	—	Preço 18/09/2026 SEC 31/12/2024
AVIRAtea Pharmaceuticals, Inc. - common stock	NASDAQ	US$ 5,33	US$ 434,37 mi	—	1,58x	-57,49%	—	Preço 18/09/2026 SEC 31/12/2025
STTKShattuck Labs, Inc. - Common Stock	NASDAQ	US$ 6,20	US$ 431,43 mi	—	5,24x	-59,24%	—	Preço 14/09/2026 SEC 31/12/2025
NBPNovaBridge Biosciences - American Depositary Shares	NASDAQ	US$ 1,59	US$ 421,95 mi	—	1,83x	-20,03%	—	Preço 11/09/2026 SEC 31/12/2025
KROSKeros Therapeutics, Inc. - common stock	NASDAQ	US$ 11,08	US$ 419,48 mi	4,82x	1,38x	28,70%	—	Preço 11/09/2026 SEC 31/12/2025
IMMXImmix Biopharma, Inc. - Common Stock	NASDAQ	US$ 12,14	US$ 400,20 mi	—	4,27x	-31,39%	—	Preço 11/09/2026 SEC 31/12/2025
CAPRCapricor Therapeutics, Inc. - Common Stock	NASDAQ	US$ 8,56	US$ 397,86 mi	—	1,30x	-34,35%	—	Preço 15/09/2026 SEC 31/12/2025
LNAILunai Bioworks Inc. - Common Stock	NASDAQ	US$ 2,38	US$ 392,85 mi	—	-18,40x	833,76%	—	Preço 11/09/2026 SEC 30/06/2025
IVAInventiva S.A. - American Depository Shares	NASDAQ	US$ 4,02	US$ 384,56 mi	—	-3,61x	172,73%	—	Preço 11/09/2026 SEC 31/12/2024
CTNMContineum Therapeutics, Inc. - Common stock	NASDAQ	US$ 13,82	US$ 382,83 mi	—	1,47x	-22,98%	—	Preço 15/09/2026 SEC 31/12/2025
IRDOpus Genetics, Inc. - Common Stock	NASDAQ	US$ 6,04	US$ 375,82 mi	—	24,49x	-323,11%	—	Preço 11/09/2026 SEC 31/12/2025
RCKTRocket Pharmaceuticals, Inc. - Common Stock	NASDAQ	US$ 3,35	US$ 372,26 mi	—	1,34x	-80,49%	—	Preço 11/09/2026 SEC 31/12/2025
ABEOAbeona Therapeutics Inc. - Common Stock	NASDAQ	US$ 5,57	US$ 368,38 mi	5,51x	2,31x	44,71%	—	Preço 18/09/2026 SEC 31/12/2025
LBRXLB Pharmaceuticals Inc - Common Stock	NASDAQ	US$ 44,71	US$ 359,70 mi	—	1,19x	-8,37%	—	Preço 14/09/2026 SEC 31/12/2025
EBSEmergent BioSolutions Inc. Common Stock	NYSE	US$ 6,23	US$ 353,24 mi	6,70x	0,68x	10,07%	—	Preço 11/09/2026 SEC 31/12/2025
PRLDPrelude Therapeutics Incorporated - Common Stock	NASDAQ	US$ 4,59	US$ 353,23 mi	—	5,15x	-144,96%	—	Preço 11/09/2026 SEC 31/12/2025
SGMTSagimet Biosciences Inc. - Series A Common Stock	NASDAQ	US$ 10,88	US$ 351,92 mi	—	3,16x	-45,82%	—	Preço 11/09/2026 SEC 31/12/2025
TTRXTurn Therapeutics Inc. - Common Stock	NASDAQ	US$ 12,69	US$ 351,72 mi	—	75,05x	-68,15%	—	Preço 11/09/2026 SEC 31/12/2025
IMRNImmuron Limited - American Depositary Shares	NASDAQ	US$ 1,45	US$ 339,24 mi	—	42,04x	-64,64%	—	Preço 11/09/2026 SEC 30/06/2025
EPRXEupraxia Pharmaceuticals Inc. - Common Stock	NASDAQ	US$ 8,42	US$ 336,43 mi	—	4,18x	-47,95%	—	Preço 11/09/2026 SEC 31/12/2025
RZLTRezolute, Inc. - Common Stock (NV)	NASDAQ	US$ 4,22	US$ 320,72 mi	—	1,98x	-45,90%	—	Preço 11/09/2026 SEC 30/06/2025
SIONSionna Therapeutics, Inc. - Common Stock	NASDAQ	US$ 7,85	US$ 313,70 mi	—	1,02x	-24,53%	—	Preço 11/09/2026 SEC 31/12/2025
UPBUpstream Bio, Inc. - Common Stock	NASDAQ	US$ 5,73	US$ 308,58 mi	—	0,91x	-42,22%	—	Preço 11/09/2026 SEC 31/12/2025

Mercado internacional de ações

Ranking de Stocks

Mais populares

Todas as ações

Maiores lucros

Maiores ROEs

Maiores altas